收藏切换
The mechanism of Danqi tablets in the treatment of coronary heart disease based on network pharmacology
收藏切换
PDF
Lin MA1, Ming-yan SHAO1, Qian-bin SUN1, Chun LI2, Yong WANG3, *
Acta Pharmaceutica Sinica | 2020, 55(12) : 2942 - 2950
Less
收藏切换
Acta Pharmaceutica Sinica | 2020, 55(12): 2942-2950
Original Articles
The mechanism of Danqi tablets in the treatment of coronary heart disease based on network pharmacology
Full
Lin MA1, Ming-yan SHAO1, Qian-bin SUN1, Chun LI2, Yong WANG3, *
Affiliations
  • 1. School of Life Science, Beijing University of Chinese Medicine, Beijing 100029, China
  • 2. School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
  • 3. School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
Published: 2020-12-12 doi: 10.16438/j.0513-4870.2020-0761
Outline
收藏切换

We used the network pharmacology to explore the active ingredients and mechanism of action of Danqi tablets in the treatment of coronary heart disease, providing a theoretical basis for the treatment of clinical coronary heart disease. The TCMSP database was used to screen for active ingredients and targets in Danqi tablets; the predicted targets of coronary heart disease were screened through the GeneCards database; then, the intersection of the two targets was mapped; we used STRING database to construct a protein interaction network map and identified 65 cores targets; then, the DAVID database was used for enrichment analysis of gene ontology (GO) biological processes and KEGG signaling pathways, and finally the Cytoscape-3.6.2 software was used to construct a network diagram of traditional Chinese medicine-active ingredient-key targets-pathway. The H2O2-induced H9C2 cells injury model was used for experimental verification. The results suggest that Danqi tablets act on inflammatory factors and apoptosis-related pathways through quercetin, luteolin, tanshinone ⅡA, and other active ingredients, and improve proinflammatory or anti-inflammatory imbalances in the body and protect cardiomyocytes. This study confirms the multi-component and multi-target effects of Danqi tablets in the treatment of coronary heart disease, and provides an objective basis for their use in further experimental research and the clinical diagnosis and treatment of coronary heart disease.

network pharmacology  /  Danqi tablet  /  coronary heart disease  /  mechanism  /  target
Lin MA, Ming-yan SHAO, Qian-bin SUN, Chun LI, Yong WANG. The mechanism of Danqi tablets in the treatment of coronary heart disease based on network pharmacology[J]. Acta Pharmaceutica Sinica, 2020 , 55 (12) : 2942 -2950 . DOI: 10.16438/j.0513-4870.2020-0761
Year 2020 volume 55 Issue 12
PDF
196
81
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2020-0761
  • Receive Date:2020-05-17
  • Online Date:2026-01-23
  • Published:2020-12-12
Article Data
Affiliations
History
  • Received:2020-05-17
  • Revised:2020-06-12
Funding
Affiliations
    1. School of Life Science, Beijing University of Chinese Medicine, Beijing 100029, China
    2. School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
    3. School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2020-0761
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT